MetALD: Clinical aspects, pathophysiology and treatmentKeypoints
Summary: Metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD) are the most prevalent causes of chronic liver disease worldwide. Both conditions have many pathophysiological mechanisms in common, such as altered lipid and bile acid metabolism, and s...
Saved in:
Main Authors: | Jordi Gratacós-Ginès, Silvia Ariño, Pau Sancho-Bru, Ramon Bataller, Elisa Pose |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | JHEP Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555924002544 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ethyl Lactate Ameliorates Hepatic Steatosis and Acute‐on‐Chronic Liver Injury in Alcohol‐Associated Liver Disease by Inducing Fibroblast Growth Factor 21
by: Yang Jiang, et al.
Published: (2025-02-01) -
Consistency analysis of two US techniques for evaluating hepatic steatosis in patients with metabolic dysfunction-associated steatotic liver disease
by: Fei Chen, et al.
Published: (2025-01-01) -
Intervention effect of ventilator‑assisted emergency endoscopy in the treatment of cirrhosis‑associated esophagogastric variceal bleeding
by: Xiu-Lian Wu, et al.
Published: (2024-11-01) -
Metabolic dysfunction-associated fatty liver disease and risk of nephrolithiasis: a sizeable cross-sectional study
by: Shengqi Zheng, et al.
Published: (2025-01-01) -
Nonlinear relationship between hepatic steatosis index and reversion to normal glucose regulation in Chinese adults with prediabetes
by: Haiyong Zeng, et al.
Published: (2025-02-01)